Trials / Completed
CompletedNCT01380964
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
Research of Biomarkers for Disease Diagnosis, Disease Monitoring and Therapeutic Treatment Response in Duchenne Muscular Dystrophy Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (actual)
- Sponsor
- Genethon · Academic / Other
- Sex
- Male
- Age
- 3 Years – 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to identify potential biomarkers for the diagnosis, disease progression assessment and response to treatment in patients with Duchenne Muscular Dystrophy.
Conditions
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2011-06-27
- Last updated
- 2016-08-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01380964. Inclusion in this directory is not an endorsement.